Vaccinex, Inc. IPO Advisory
Share this IPO Profile:
Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
Vaccinex, Inc. | VCNX - NASDAQ |
$12.00-$15.00 |
$12.00 |
$12.00 | 3.3 million | 8/9/2018 |
Oppenheimer & Co., BTIG |
Co-Manager(s): Ladenburg Thalmann |
Health Care |
Filing(s): Filed 2018-07-09 Terms Added 2018-07-23
|
For IPO Boutique's "scale of 1 to 5" BUY rating on Vaccinex, Inc. , and our comprehensive analysis, click "Buy Market Research".
Vaccinex, Inc. Quote & Chart - Click for current quote -
VCNX
About Vaccinex, Inc. (adapted from Vaccinex, Inc. prospectus):
They are a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "VCNX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2024 IPO Boutique. All Rights Reserved